Gene: C2orf88
Official Full Name: chromosome 2 open reading frame 88provided by HGNC
Gene Summary: Predicted to enable protein kinase A regulatory subunit binding activity. Predicted to be located in plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO24983 | C2orf88 Knockout cell line (HCT 116) | Human | C2orf88 | 1:2~1:4 | Negative | Online Inquiry |
KO24984 | C2orf88 Knockout cell line (HEK293) | Human | C2orf88 | 1:3~1:6 | Negative | Online Inquiry |
KO24985 | C2orf88 Knockout cell line (A549) | Human | C2orf88 | 1:3~1:4 | Negative | Online Inquiry |
C2orf88 Gene Knockout Cell Lines are advanced biological tools designed for the functional study of the C2orf88 gene, an uncharacterized gene implicated in various cellular processes. By utilizing CRISPR-Cas9 gene-editing technology, these knockout cell lines allow researchers to selectively deactivate the C2orf88 gene, enabling the assessment of its role in cellular function and pathology.
The key function of these knockout cell lines is to provide a controlled experimental model in which researchers can investigate the biochemical and physiological consequences of C2orf88 gene loss. Through systematic analysis of cellular behavior, signaling pathways, and gene expression profiles, scientists can elucidate the gene’s involvement in processes such as cell proliferation and apoptosis, as well as its potential link to diseases, including cancer and other genetic disorders.
The scientific importance of C2orf88 Gene Knockout Cell Lines lies in their diverse applications across both research and clinical settings. They serve as essential platforms for drug development, disease modeling, and validation of new therapeutic targets. By providing clear insights into gene function, these cell lines support broader genomic studies and pave the way for precision medicine approaches.
What sets our C2orf88 Gene Knockout Cell Lines apart from alternative models is their high efficiency and specificity, coupled with robust validation data that confirms gene disruption. Unlike other methods that may produce off-target effects, our cell lines ensure reliable and reproducible results, enhancing the rigor of scientific investigations.
For researchers and clinicians, the ability to study the functional implications of the C2orf88 gene in a controlled environment offers significant value in advancing their understanding of complex biological processes. Our commitment to quality and innovation in biotechnology has established our company as a leading provider of gene-editing solutions, ensuring that our products meet the highest standards of scientific excellence and research utility.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.